WaveMan · Form 4
Fmr LLC insider trades
> Search tickers & screens ⌘K
LIVE

Fmr LLC insider trades

Fmr LLC has filed 48 Form 4s with the SEC that we hold, for Structure Therapeutics Inc. (GPCR) (10% owner), Beam Therapeutics Inc. (BEAM) (10% owner), MTSR (10% owner) and VERV (Reporting owner), among 14 companies in all. Across all of them we count 3 purchases worth $8.8M and 35 sales worth $54.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($10.1M). The largest single trade was a sale of 854,323 shares of Beam Therapeutics Inc. worth $26.1M, dated 2024-02-14. The first filing on our record is dated 2021-07-29 and the latest 2026-07-24.

Structure Therapeutics Inc. (GPCR)

10% owner · 12 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Beam Therapeutics Inc. (BEAM)

10% owner · 11 filings · 15 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-04-13S, sale reported on Form 43,200$162.6K2022-04-14
2022-04-13S, sale reported on Form 4663$33.6K2022-04-14
2022-04-13S, sale reported on Form 46,799$344.7K2022-04-14
2022-04-13S, sale reported on Form 48,804$440.3K2022-04-14
2022-08-05S, sale reported on Form 420,159$1.2M2022-08-08
2022-08-05S, sale reported on Form 4167$10.2K2022-08-08
2022-09-06S, sale reported on Form 4551$29.9K2022-09-08
2024-02-13S, sale reported on Form 4410$12.4K2024-02-15
2024-02-13S, sale reported on Form 41,155$35.7K2024-02-15
2024-02-14S, sale reported on Form 445,677$1.4M2024-02-15
2024-02-14S, sale reported on Form 4854,323$26.1M2024-02-15
2025-07-30S, sale reported on Form 448,374$991.7K2025-08-01
2025-10-27S, sale reported on Form 4459$12.2K2025-10-29
2026-06-25S, sale reported on Form 433,372$1.2M2026-06-29
2026-06-26S, sale reported on Form 4251,488$8.9M2026-06-29

MTSR

10% owner · 7 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-09-02S, sale reported on Form 4268$9.6K2025-09-04
2025-11-03S, sale reported on Form 4193$11.8K2025-11-05

VERV

Reporting owner · 7 filings · 14 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-01-26S, sale reported on Form 488,989$2.8M2022-01-28
2022-01-26S, sale reported on Form 414,918$442.6K2022-01-28
2022-01-26S, sale reported on Form 445,946$1.5M2022-01-28
2022-01-27S, sale reported on Form 4247$7.4K2022-01-28
2022-01-27S, sale reported on Form 48,736$255.6K2022-01-28
2022-02-01S, sale reported on Form 435,574$1.0M2022-02-03
2022-02-09S, sale reported on Form 413,190$388.6K2022-02-11
2022-03-09S, sale reported on Form 43,971$115.2K2022-03-11
2022-06-29S, sale reported on Form 44,047$62.7K2022-07-01
2022-06-29S, sale reported on Form 430,362$473.6K2022-07-01
2022-06-30S, sale reported on Form 418,810$286.1K2022-07-01
2022-07-01S, sale reported on Form 438,775$607.2K2022-07-06
2022-07-12S, sale reported on Form 463,000$1.4M2022-07-14
2022-07-12S, sale reported on Form 4100,000$2.0M2022-07-14

CIK 1920453

10% owner · 2 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-06-27P, purchase reported on Form 4346,723$8.7M2023-06-29
2023-11-29P, purchase reported on Form 4392$10.0K2023-11-29
2023-11-29P, purchase reported on Form 4392$10.0K2023-11-29

Avalyn Pharma Inc. (AVLN)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Bicara Therapeutics Inc. (BCAX)

Reporting owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Caribou Biosciences, Inc. (CRBU)

Reporting owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Neumora Therapeutics, Inc. (NMRA)

Reporting owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Prime Medicine, Inc. (PRME)

Reporting owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Rallybio Corp (RLYB)

Reporting owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Sana Biotechnology, Inc. (SANA)

10% owner · 1 filing · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-01-08S, sale reported on Form 4100,000$611.0K2025-01-10
2025-01-08S, sale reported on Form 4164,912$1.1M2025-01-10
2025-01-08S, sale reported on Form 41,000$7.3K2025-01-10
2025-01-08S, sale reported on Form 425,000$162.5K2025-01-10

TSBX

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Xilio Therapeutics, Inc. (XLO)

Reporting owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 315066) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms